Questcor and Child Neurology Foundation Support the 5th Annual Infantile Spasms Awareness Week

   Questcor and Child Neurology Foundation Support the 5th Annual Infantile
                            Spasms Awareness Week

- IS Hero Award goes to Dr. Carolina Amador and the staff at Lincoln Health
Center, Corvallis, Oregon

PR Newswire

HAYWARD, Calif., Dec. 9, 2013

HAYWARD, Calif., Dec. 9, 2013 /PRNewswire/ --Questcor Pharmaceuticals, Inc.
(NASDAQ: QCOR) today announced that it is partnering with the Child Neurology
Foundation (CNF) in support of the 5^th annual Infantile Spasms Awareness
Week, which is taking place this week.

As part of this education effort, CNF has developed a website,
www.infantilespasmsinfo.org, that provides information on IS from leading
child neurologists and shares stories from families coping with this
devastating condition. Earlier this year, CNF launched the Infantile Spasms
Parent Mentor Network on the website so that parents of newly-diagnosed
children can connect directly with parents who have been through a similar
experience with their child. CNF has also developed an educational IS
brochure and DVD that it makes available to physicians and parents alike.

This year, CNF is also launching a "mini-grants" program for infantile spasms,
funded by a new grant from Questcor, that will allow parents to apply for
funding to pay for needed services for their children (from speech therapy to
wheelchairs to learning aids) that are not covered by insurance. CNF is
administering the program, and overseeing all elements of the application
process and the disbursement of funds.

"Questcor is privileged to continue its five-year partnership with the Child
Neurology Foundation," said Steve Cartt, Chief Operating Officer for Questcor.
"The goal of Infantile Spasms Awareness Week is to provide pediatricians,
child neurologists, parents, and caregivers with objective educational tools
which will help increase awareness and understanding of this very rare form of
epilepsy. We are committed to supporting both the infantile spasms community
and the child neurologists who treat children suffering from this potentially
devastating condition."

As part of Infantile Spasms Awareness Week, the CNF announced that Dr.
Carolina Amador and the staff at Lincoln Health Center in Corvallis, Oregon,
have been selected as this year's Infantile Spasms Hero.

John Stone, executive director of the CNF, commented, "The IS Hero Award
recognizes a deserving physician and medical institution, nominated by a
parent, for making a positive difference in the life of a child with IS. This
is another way we can draw attention to IS and recognize the important
contributions made by child neurologists and pediatricians in the care of
these infants."

Dr. Amador was nominated by Rachel Harrington whose daughter was cared for by
Dr. Amador after initially being misdiagnosed, a common occurrence in children
with IS:

"Dr. Carolina Amador sets the bar for what we need from pediatricians when
treating Infantile Spasms," Rachel Harrington said in her nomination
statement. "When I called her office and described what my daughter was
doing, she made time to get her in for an appointment within 24 hours. When
shown the home video of my daughter's spasms, she recognized right away that
this was a neurologic event and immediately ordered an EEG. She mentioned that
she suspected infantile spasms, but knew that it should be confirmed.

"Dr. Amador traveled two hours to the hospital to see us on a Sunday and
encouraged us to stay until we could get a second opinion. Only after staying
an additional night and meeting with the head child neurologist at the
hospital did my daughter receive her correct diagnosis (of infantile spasms).

"My daughter went seven days from her first spasm to the diagnosis and control
of them. This is unprecedented and a major factor for why my daughter is doing
so well today. If Dr. Amador had not done what she did to facilitate the
immediate testing and if she had not encouraged us to stay for a second
opinion, there is truly no telling how long we would have waited for a correct
diagnosis and how much damage would have been done. Dr. Amador is a true hero
to us and, in our house, her name is spoken with reverence."

Stone also announced that Heather Olson, MD, of Children's Hospital in Boston
was selected to receive its annual IS Research Award, also supported by
Questcor. Dr. Olson's research is focused on understanding the genetic causes
of infantile spasms and related epilepsies.

"Questcor has been a terrific partner to work with over the past five years,"
Stone commented. "Their funding has helped provide support that would
otherwise not occur because of the ultra-rare nature of infantile spasms."

Infantile Spasms
Infantile Spasms is a severe, ultra-rare form of epilepsy that affects
infants, with onset typically occurring during the first year of life in about
90 percent of cases. IS incidence is estimated at approximately 2,000 new
cases in the U.S. per year, which can be classified as an ultra-orphan
disease. For comparison, orphan disease designation pertains to diseases that
affect fewer than 200,000 people. IS patients experience rapid, characteristic
muscular contraction or extensions lasting one to two seconds and occurring in
clusters ranging from a few spasms to more than 100 spasms per cluster. Often,
in the beginning, the attacks are brief, infrequent and not typical, so it is
quite common for the diagnosis to be delayed. Frequently, due to the pattern
of the attacks and the cry that an infant gives during or after an attack, the
attacks are sometimes initially thought to be due to colic or gastric
distress.

About the Child Neurology Foundation
Founded in October 2000, the Child Neurology Foundation was created as the
outreach and philanthropic arm of the Child Neurology Society. Members of the
CNS include more than 1,300 child neurologists from the United States, Canada,
as well as more than 30 other countries around the world.

The Foundation's mission is to advocate for children and adolescents with
neurologic and developmental disorders; fund neurologic research of young
investigators; promote awareness of career opportunities in child neurology;
provide public, professional, and patient education programs; and support the
activities and mission of the CNS.

For more information on the CNF, please visit
www.childneurologyfoundation.org.

About Questcor Pharmaceuticals
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
treatment of patients with serious, difficult-to-treat autoimmune and
inflammatory disorders. Questcor's specific areas of focus are in the fields
of neurology, nephrology and rheumatology, and the company is currently
supporting research efforts in a variety of conditions having significant
unmet medical need. For more information about Questcor, please visit
www.questcor.com.

SOURCE Questcor Pharmaceuticals, Inc.

Website: http://www.questcor.com
Contact: For More Information: Mark Leonard, 847-651-9682,
mark@reachthenextlevel.com
 
Press spacebar to pause and continue. Press esc to stop.